Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

A new human leukemia cell 8.2 kDa differentiation factor: isolation and primary structure

I A Kostanyan1, M V Astapova, E V Starovoytova

  • 1Shemyakin and Ovchinnikov Institute of Bioorganic Chemistry, Russian Academy of Science, Moscow.

FEBS Letters
|December 19, 1994
PubMed
Summary

Researchers purified a novel 8.2 kDa differentiation factor from human leukemia cells. This protein, crucial for cell differentiation, was characterized via cDNA sequencing and glycosylation analysis, revealing its molecular properties.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[The effect of acetylamide synthetic peptide HLDF-6 on cell differentiation in breast cancer].

Arkhiv patologii·2025
Same author

[Influence of the HLDF differentiation factor on the production of cytokines by bio-tissues of breast tissue in its non-malignant diseases and in invasive carcinoma of a non-specific type].

Biomeditsinskaia khimiia·2020
Same author

Influence of HLDF Differentiation Factor on Nonspecific Invasive Breast Carcinoma in vitro.

Doklady. Biochemistry and biophysics·2020
Same author

Influence of Internal and External Factors on the Production of Cytokines by Peripheral Blood Cells in Breast Cancer.

Doklady. Biochemistry and biophysics·2020
Same author

Topological Features of Histone H2A Monoubiquitination.

Doklady. Biochemistry and biophysics·2020
Same author

[Proteins and immunohistochemical markers of breast diseases].

Biomeditsinskaia khimiia·2020

Area of Science:

  • Molecular Biology
  • Cell Biology
  • Biochemistry

Background:

  • Human myelogenous leukemia (HL-60) cells are a model for studying cell differentiation.
  • Retinoic acid is a known inducer of differentiation in various cell types.
  • Understanding differentiation factors is key to controlling cell fate in leukemia.

Purpose of the Study:

  • To isolate and characterize a novel differentiation factor from retinoic acid-induced HL-60 cells.
  • To determine the molecular properties and genetic sequence of this factor.
  • To investigate the factor's role in regulating gene expression during differentiation.

Main Methods:

  • Purification of the 8.2 kDa differentiation factor from cell culture media.
  • Construction and screening of a cDNA library from differentiated HL-60 cells.

Related Experiment Videos

  • Nucleotide sequencing of isolated cDNA clones.
  • Analysis of protein glycosylation.
  • Northern blot analysis to assess RNA levels.

    • Main Results:

    • A homogeneous 8.2 kDa differentiation factor was purified.
    • cDNA clones encoding the factor were isolated, revealing a 54-amino acid sequence.
    • The protein was confirmed to be glycosylated.
    • Northern blot showed increased levels of 450-nucleotide poly(A)+ RNA in differentiated cells.

    Conclusions:

    • A novel glycosylated differentiation factor has been identified and characterized.
    • The factor plays a role in the differentiation of HL-60 leukemia cells.
    • Its expression correlates with specific changes in RNA levels during differentiation.